Innovative Diagnostic Technology
Brisbane company, Panbio Ltd, has been offered one of the first grants under the Australian Government’s new $1 billion Commercial Ready program to develop leading-edge diagnostic technology to test for a range of infectious diseases.
The $3.5 million grant will further R&D on “Forced Enzyme Complementation” technology, the next generation of diagnostic tools used for the testing and identification of specific diseases, particularly high infectious ones.
Panbio Ltd has developed more than 90 diagnostic tests which are used in clinical laboratories to check for about 30 diseases like Ross River, Dengue or glandular fever and whooping cough. Last year the company produced kit tests to assist in the diagnosis and treatment of more than four million people in Australia, New Zealand, Asia, the Americas, Europe, the Middle East and Africa.
The company expects the new technology to generate significant national and export income as it replaces current testing methods.
For information on this article, or on any other aspect of the Australian economy or business opportunities available, please email me.
David
david.taylor@agarcarlyon.com